DERMATA THERAPEUTICS, INC.

DRMA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents $4.4M $6.9M $7.5M $4.7M $6.5M $9.7M $3.2M $6.1M
Accounts Receivable
Inventory $149.7K $93.1K
Total Current Assets $5.2M $7.9M
Property, Plant & Equipment $129.4K
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $5.3M $7.5M $7.9M $5.1M $6.6M $10.0M $3.5M $6.7M
Liabilities
Accounts Payable $1.1M $318.3K $460.8K $453.4K $413.7K $1.4M $808.0K $863.6K
Total Current Liabilities
Long-Term Debt
Total Liabilities $1.8M $1.1M $1.6M $1.1M $1.0M $2.7M $2.0M $1.9M
Stockholders' Equity
Retained Earnings $-78.0M $-75.1M $-73.2M $-71.4M $-69.7M $-68.0M $-65.7M $-62.5M
Total Stockholders' Equity $3.5M $6.4M $6.2M $4.0M $5.6M $7.3M $1.6M $4.7M
← Newer Page 1 of 3 Older →